SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-15-006596
Filing Date
2015-04-24
Accepted
2015-04-24 19:00:52
Documents
2
Period of Report
2015-04-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3196
2 POWER OF ATTORNEY ringpoa.txt EX-24.TXT 3387
  Complete submission text file 0001179110-15-006596.txt   7981
Mailing Address C/O BRISTOL MYERS SQUIBB CO 345 PARK AVE NEW YORK NY 10164
Business Address
RINGROSE PETER S (Reporting) CIK: 0001199298 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36033 | Film No.: 15793125

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations